NRx Pharma Gains Rights To Data From Columbia University Supporting Use Of IV Ketamine
NRx Pharmaceuticals, Inc. (NRXP) has signed a License Data and Technical Information Agreement with Columbia University for rights to data from a randomized, active-controlled trial of 80 patients hospitalized for Acute Suicidality in Depression.
Source: rttnews.com